Biglycan Polyclonal antibody

• Featured Product
• KD/KO Validated

Biglycan Polyclonal Antibody for IF, IHC, WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat, pig

Applications

WB, IHC, IF, Cell treatment, ELISA

Conjugate

Unconjugated

Publications

21

Cat no : 16409-1-AP

Synonyms

A6NLG9, BGN, biglycan, Bone/cartilage proteoglycan I, DSPG1, PG S1, PGI, SLRR1A

---

Validation Data Gallery

• 

  WB analysis using 16409-1-AP

  COLO 320 cells were subjected to SDS PAGE followed by western blot with 16409-1-AP (Biglycan antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HeLa using 16409-1-AP

  HeLa cells were subjected to SDS PAGE followed by western blot with 16409-1-AP (BGN antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HepG2 using 16409-1-AP

  HepG2 cells were subjected to SDS PAGE followed by western blot with 16409-1-AP (BGN antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of mouse skeletal muscle using 16409-1-AP

  mouse skeletal muscle tissue were subjected to SDS PAGE followed by western blot with 16409-1-AP (BGN antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours.

• 

  WB analysis of pig cartilage using 16409-1-AP

  pig cartilage tissue were subjected to SDS PAGE followed by western blot with 16409-1-AP (Biglycan Antibody) at dilution of 1:300 incubated at room temperature for 1.5 hours.

• 

  IHC staining of human lung using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human lung using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 40x lens).

• 

  IHC staining of human lung using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung using 16409-1-AP (BGN antibody) at dilution of 1:25 (under 10x lens).

• 

  IHC staining of human lung using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung using 16409-1-AP (BGN antibody) at dilution of 1:25 (under 40x lens).

• 

  IHC staining of human liver cancer using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human liver cancer using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human liver cancer using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human liver cancer using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 40x lens).

• 

  IHC staining of human liver cancer using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human liver cancer using 16409-1-AP (BGN antibody) at dilution of 1:25 (under 10x lens).

• 

  IHC staining of human liver cancer using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human liver cancer using 16409-1-AP (BGN antibody) at dilution of 1:25 (under 40x lens).

• 

  IHC staining of human renal cell carcinoma using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human renal cell carcinoma using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human renal cell carcinoma using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human renal cell carcinoma using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 40x lens).

• 

  IHC staining of mouse lung using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded mouse lung using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of mouse lung using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded mouse lung using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 40x lens).

• 

  IHC staining of human stomach cancer using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human stomach cancer using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human stomach cancer using 16409-1-AP

  Immunohistochemical analysis of paraffin-embedded human stomach cancer using 16409-1-AP (BGN antibody) at dilution of 1:50 (under 40x lens).

• 

  IF Staining of HepG2 using 16409-1-AP

  Immunofluorescent analysis of HepG2 cells using 16409-1-AP (Biglycan antibody) at dilution of 1:50 and Alexa Fluor 488-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L).

---

Tested Applications

• Positive WB detected in: COLO 320 cells, mouse skeletal muscle tissue, HeLa cells, HepG2 cells, pig cartilage tissue
• Positive IHC detected in: human lung tissue, human liver cancer tissue, human renal cell carcinoma tissue, human stomach cancer tissue, mouse lung tissue; Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
• Positive IF detected in: HepG2 cells

Recommended dilution

• Western Blot (WB): WB : 1:500-1:2000
• Immunohistochemistry (IHC): IHC : 1:20-1:200
• Immunofluorescence (IF): IF : 1:20-1:200

Sample-dependent, check data in validation data gallery

Published Applications

• KD/KO: See 1 publications below
• WB: See 14 publications below
• IHC: See 7 publications below
• IF: See 7 publications below

Product Information

The immunogen of 16409-1-AP is Biglycan Fusion Protein expressed in E. coli.

• Tested Reactivity: human, mouse, rat, pig
• Cited Reactivity: human, mouse, rat
• Host / Isotype: Rabbit / IgG
• Class: Polyclonal
• Type: Antibody
• Immunogen: Biglycan fusion protein Ag0683
• Full Name: biglycan
• Calculated molecular weight: 42 kDa
• Observed molecular weight: 40-48 kDa
• GenBank accession number: BC004244
• Gene symbol: BGN
• Gene ID (NCBI): 633
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Antigen affinity purification
• Storage Buffer: PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
• Storage Conditions: Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20^oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Biglycan is a member of the small leucine-rich proteoglycan (SLRP) family (PMID: 18463092). It consists of a core protein of 42 kDa containing leucine-rich repeats (LRRs), to which two chondroitin/dermatan sulfate side chains are covalently bound (PMID: 2212616; 10383378). The tissue-specific chondroitin- or dermatan-sulfate glycosaminoglycan chains of biglycan are attached to amino acid residues at the N-terminus of the core protein (PMID: 22821552). Biglycan is a ubiquitous component of connective tissue matrix and may act as a signaling molecule (PMID: 22821552). Upregulation of biglycan has been reported in multiple types of solid cancer (PMID: 32194659).

Publications

Species	Application	Title
human	WB,IHC	Oncoimmunology; Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer.; Authors - Shaoquan Zheng
human	WB,IF	Cancers (Basel); Biglycan Promotes Cancer Stem Cell Properties, NFκB Signaling and Metastatic Potential in Breast Cancer Cells.; Authors - Kanakaraju Manupati ; KD Validated
human	WB,IHC	Oncoimmunology; Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.; Authors - Karthikeyan Subbarayan
rat	IF	Cell Prolif; Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway.; Authors - Yunjiao Wang
human	IHC	Cancer Med; Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma; Authors - Wanyi Xiao
	WB	J Proteome Res; Multi-Proteomic Analysis Reveals the Effect of Protein Lactylation on Matrix and Cholesterol Metabolism in Tendinopathy; Authors - Yuan Lin

Related Products

Decorin Polyclonal antibody

14667-1-AP

Aggrecan Polyclonal antibody

13880-1-AP

TGF Beta 1 Polyclonal antibody

18978-1-AP

Collagen Type II Polyclonal antibody

15943-1-AP

Elastin Polyclonal antibody

15257-1-AP